APL

What APL does

APL (PT Anugerah Pharmindo Lestari) is Indonesia's largest pharmaceutical distribution and healthcare services company, operating as a subsidiary of Zuellig Pharma Group since a 2005 joint venture. Founded in 1985, APL delivers an integrated three-pillar platform: pharmaceutical distribution (reaching 67,000+ healthcare facilities across 434 cities through 46 distribution points, 88 regional sub-distributors, and a 39,930 sqm National Distribution Center in Cikarang); commercialization services (covering 66.25% of healthcare professionals across 13 therapeutic classes via 386 medical representatives and a 391-person sales force); and clinical trial support (cold chain, secondary labeling, regulatory insight). The company also runs EZ Rx, branded as ASEAN's largest B2B healthcare eCommerce platform, alongside proprietary ZP Data Analytics, Sales Force Automation, and real-time cold chain monitoring systems.

The technology stack combines a SAP-based ERP (deployed since 2001), FarEye-powered transport management, real-time temperature monitoring with automated alerts, the eZCooler cold-chain packaging system, and a digital ecosystem of B2B eCommerce (EZ Rx), data analytics, and HCP engagement tools. Distribution, commercial, and clinical trial operations are supported by 3,000+ product licenses and a regulatory stack that includes GDP certification from BPOM, GSDP, cGMP, ISO 9001:2015, ISO 27001, ISO 45001, EcoVadis Platinum, and Halal Distribution — yielding a 99.9% temperature-excursion-free CTM shipment rate and recognition in the top 1% of organizations globally for sustainability performance.

APL monetizes through four revenue streams: transaction-fee-based pharmaceutical distribution across six verticals (Pharmaceutical, Vaccines, Consumer Healthcare, Medical Device and Diagnostic, Specialty Care, Animal Health); managed services commercialization partnerships with 50+ global pharma principals; professional services for clinical trial supply and logistics; and subscription/recurring digital and data analytics revenue. Go-to-market combines enterprise field sales, channel partner sub-distributors, modern trade distribution, and direct-to-SMB eCommerce via EZ Rx. Customers are split between enterprise (global pharmaceutical manufacturers, government health institutions) on the upstream side and SMB/mid-market healthcare providers on the downstream side.

Name

APL

Legal name

PT Anugerah Pharmindo Lestari

Website

https://aplcare.com

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

APL (PT Anugerah Pharmindo Lestari) is Indonesia's largest pharmaceutical distribution and healthcare services company, providing distribution, commercialization, and clinical trial support to 50+ global pharma principals and 67,000+ healthcare facilities across 434 cities as a Zuellig Pharma subsidiary.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Pharmacy Benefit/Channel Services (PSAO, 340B Admin, Chargebacks/Rebates Ops) (CRAOAHAK)

akta.pro secondary industries

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)

Keywords

• Pharmaceutical distribution
• Healthcare commercialization
• Clinical trial supply
• Cold chain logistics
• Pharmacy eCommerce

Headquarters

HQ city

Jakarta

HQ country

Indonesia

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Comprehensive distribution services for pharmaceutical products through extensive channel coverage reaching clinics, hospitals, pharmacies, laboratories, and modern trade outlets across Indonesia. Revenue generated from distribution fees and product handling across 67,000 customer touchpoints.
2. Healthcare Commercialization: End-to-end commercial solutions including marketing excellence, sales excellence, medical affairs, alliance management, and regulatory services. Revenue derived from commercialization partnerships with pharmaceutical companies.
3. Clinical Trial Support: End-to-end clinical trial supply and logistics solutions including clinical storage and distribution, cold chain management, clinical sourcing, secondary labeling, and regulatory insight services.
4. Digital and Data Analytics: Digital solutions including B2B eCommerce platform EZ Rx, data analytics services, and sales force automation tools for healthcare ecosystem optimization.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

APL is Indonesia's largest pharmaceutical distribution and healthcare services company, providing three integrated service platforms: (1) Distribution — end-to-end pharmaceutical supply chain across 67,000+ customers in 434 cities, supported by a 39,930 sqm National Distribution Center, advanced cold-chain infrastructure, and ASEAN's largest B2B healthcare eCommerce platform EZ Rx; (2) Commercialization — marketing, sales, medical affairs, alliance management, and regulatory services delivered through 386 medical representatives across 13 therapeutic classes; and (3) Clinical Trial Support — globally compliant clinical storage, distribution, cold chain management, sourcing, secondary labeling, and regulatory insight services for global clinical trials.

Product overview

APL (PT Anugerah Pharmindo Lestari) is a leading healthcare services company in Indonesia offering an integrated platform of three core services: Distribution, Commercialization, and Clinical Trial Support. The Distribution platform includes physical infrastructure (National Distribution Center in Cikarang, 46 distribution points, 88 regional sub-distributors) and technology products like EZ Rx (ASEAN's largest B2B healthcare eCommerce platform), Real-Time Transport Management System, and Real-Time Temperature Monitoring System. The Commercialization platform provides Marketing Excellence, Sales Excellence (with Sales Force Automation), Medical Affairs, Alliance Management, and Regulatory services across 13 therapeutic classes with 386 Medical Representatives covering 66.25% HCP coverage. The Clinical Trial Support platform offers end-to-end solutions including clinical storage/distribution, cold chain management, clinical sourcing, secondary labeling, and regulatory insight. The Digital & Data Analytics product (ZP Data Analytics) spans commercial analytics, supply chain analytics, and business intelligence across these core services. APL serves six healthcare segments: Pharmaceutical, Vaccines, Consumer Healthcare, Medical Device and Diagnostic, Specialty Care, and Animal Health.

Differentiator

Problem solved

Functional benefit

Brands

• EZ Rx: ASEAN's largest B2B healthcare eCommerce platform for pharmacies and clinics.
• eZCooler

Products and services

• Pharmaceutical Distribution Services End-to-end pharmaceutical distribution services covering 67,000+ clinics, hospitals, pharmacies, laboratories, and modern trade outlets across 434 cities in Indonesia. Includes temperature-sensitive handling and nationwide channel coverage through 46 distribution points and 88 regional sub-distributors.
• Commercialization Services End-to-end commercial solutions for the healthcare industry covering marketing excellence, sales excellence, medical affairs, alliance management, and regulatory support. Delivered through 386 medical representatives across 13 therapeutic classes with 66.25% HCP coverage, designed to expand patient access for global pharmaceutical partners.
• Clinical Trial Support End-to-end clinical trial supply chain solutions including clinical storage and distribution, cold chain management, clinical sourcing, secondary labeling, and regulatory insight services for global clinical trials, with 99.9% of controlled CTM shipments arriving without temperature excursions.
• EZ Rx B2B Healthcare eCommerce Platform ASEAN's largest B2B healthcare eCommerce platform enabling self-service medication purchasing for pharmacies and clinics through user-friendly web and mobile interfaces, simplifying order management across Indonesia.
• ZP Data Analytics Data analytics solution spanning commercial analytics (targeting and engagement insights), supply chain analytics (automated demand planning and forecasting), and business intelligence (data management and dashboarding) for the healthcare ecosystem.
• Sales Force Automation Integrated mobile solution for tracking and oversight of sales force activities, optimizing sales processes, maximizing administrative effectiveness, and minimizing time spent on order and reporting processes.
• Real-Time Transport Management System Logistics solution offering real-time tracking and close monitoring of vehicle movements with route adjustments for better service efficiency across Indonesia's distribution network.
• Real-Time Temperature Monitoring System 24/7 cold chain monitoring solution with automated alerts delivered through a secure online dashboard, providing continuous surveillance across warehousing and transportation to support regulatory compliance and product quality.
• Cold Chain Solutions (eZCooler)
• Pharmaceutical Warehousing Services Pharma-grade warehouse facilities following strict quality standards with required regulatory licenses and good storage and distribution practice, including three temperature regimes (ambient, air conditioned, cold room) at the Cikarang National Distribution Center.
• Redressing Services End-to-end redressing and waste management solutions delivered from cGMP-certified facilities in Cikarang and Central Java, with the Cikarang facility also holding Cosmetic GMP certification.

Quantifiable outcome

• 99.9% of all controlled CTM shipments arrive without temperature excursions
• +3 more outcomes

Named customers7 records

Segments7 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature8 records

Partnerships

Seven partnerships are on record, tiered core and flagship.

• IBMcoreTechnology or Integration · 1 January 2018Collaboration with IBM in 2018 to advance data-driven innovation and digital capabilities, supporting APL's digital transformation initiatives.
• Zuellig Pharma GroupflagshipStrategic or Co-development Partner · 1 January 2005APL entered a joint venture with Zuellig Pharma Group in 2005, becoming part of the largest healthcare services group in Asia. This partnership enabled APL to accelerate growth and expand capabilities beyond traditional distribution into commercialization and clinical trial support services.
• FarEyecoreTechnology or IntegrationTransportation Management System (TMS) partnership providing real-time visibility, efficient route planning, and enhanced customer engagement for logistics operations across Indonesia.
• DocQuitycoreStrategic or Co-development PartnerDigital platform partnership connecting healthcare professionals for continuous medical education. DocQuity is Southeast Asia's #1 digital platform with 80,000+ doctors connected across Indonesia.
• PT Metro Drug IndonesiacoreStrategic or Co-development PartnerAcquired in 2018 as part of expansion into commercialization services, strengthening end-to-end healthcare solutions capabilities.
• APL PharmalinkcoreStrategic or Co-development PartnerAcquired in 2018 to expand commercialization capabilities and deliver comprehensive healthcare solutions across Indonesia.
• Global Pharmaceutical PartnerscoreChannel Partner/ Reseller/ DistributorServing more than 50 global pharmaceutical companies as distribution and commercialization partner, providing end-to-end solutions for market access in Indonesia.

Scale indicators12 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• Zuellig Pharma: Parent company of APL and the largest healthcare services group in Asia, operating across multiple Southeast Asian and Asia-Pacific markets. Directly comparable because it provides the same pharmaceutical distribution, commercialization, and clinical trial support services as APL across a broader geographic footprint.
• DKSH Healthcare: Regional Market Expansion Services provider for healthcare companies across Southeast Asia, offering similar pharmaceutical distribution, commercialization, and clinical trial support services. Comparable because DKSH operates across multiple Asian markets with overlapping service offerings to global pharma manufacturers seeking ASEAN market access.
• McKesson: One of the largest pharmaceutical distribution and healthcare services companies globally, operating North American wholesale drug distribution at massive scale. Comparable as a broad incumbent in pharmaceutical distribution with similar cold chain, specialty distribution, and biopharma services that global pharma partners could leverage.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution and solutions company providing drug distribution, specialty distribution, and biopharmaceutical services worldwide. Comparable as a broad incumbent offering similar cold chain, specialty pharma, and global pharma partnership capabilities to those APL provides in Indonesia.
• Cardinal Health: Major US-based pharmaceutical and medical product distributor with global operations, providing similar drug distribution, specialty, and clinical trial support services. Comparable as a broad incumbent that global pharma partners could potentially leverage to enter or expand in the Indonesian market.

Direct peers

• Combiphar: Indonesian pharmaceutical company with distribution, manufacturing, and consumer healthcare operations, directly competing with APL in the Indonesian market. Serves similar healthcare provider and pharmacy customer base with overlapping therapeutic categories and channel coverage.
• Indofarma: Indonesian state-owned pharmaceutical manufacturer and distributor operating across pharma production, distribution, and healthcare services. Directly comparable as a domestic Indonesian pharma distribution player competing for the same manufacturer partnerships and downstream customer accounts.
• Soho Global Health: Indonesian integrated pharmaceutical company with manufacturing, distribution, and retail pharmacy operations, serving similar customers and therapeutic categories. Directly comparable as a domestic Indonesian pharma player with overlapping distribution and commercialization capabilities.
• Kalbe Farma: Indonesia's largest pharmaceutical company with manufacturing, distribution, and consumer health operations across the country. Directly comparable as a leading Indonesian pharma distribution competitor with extensive nationwide reach, distribution infrastructure, and a broad therapeutic portfolio overlapping with APL's served customers.

Emerging players

• Paragon Technology and Innovation: Indonesian consumer healthcare and pharmaceutical company with growing distribution and brand operations. Comparable as an emerging Indonesian healthcare player that competes for consumer healthcare distribution contracts and pharmacy relationships in overlapping channels.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat7 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/pt-apl-zuellig-pharma-company-
• Facebookfacebook.com/profile.php

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about APL